- Concept UI
- M000626116
- Scope Note
- A small GPI-linked glycoprotein expressed on the surface of normal and malignant B-CELLS; T-CELLS; MONOCYTES; MACROPHAGES; NK CELLS; and GRANULOCYTES. It is expressed densely and without modulation in many malignant T-cell neoplasms and therefore a target for antibody therapies (e.g., ALEMTUZUMAB).
- Terms
-
CD52 Antigen
Preferred Term
Term UI
T000915074
Date02/01/2017
LexicalTag
ABX
ThesaurusID
NLM (2018)
-
CDw52 Antigen
Term UI
T000915075
Date02/01/2017
LexicalTag
ABX
ThesaurusID
NLM (2018)
-
Campath-1 Antigen
Term UI
T000915076
Date02/01/2017
LexicalTag
NON
ThesaurusID
NLM (2018)
-
Campath-1H Antigen
Term UI
T000915077
Date02/01/2017
LexicalTag
NON
ThesaurusID
NLM (2018)
-
CD52 Protein
Term UI
T000915078
Date02/01/2017
LexicalTag
ABX
ThesaurusID
NLM (2018)
-
Lymphocyte Antigen CD52
Term UI
T000915080
Date02/01/2017
LexicalTag
ABX
ThesaurusID
NLM (2018)
-
Campath-1 Receptor
Term UI
T000915081
Date02/01/2017
LexicalTag
NON
ThesaurusID
NLM (2018)
-
HLA-Bw52 Antigen
Term UI
T000915082
Date02/01/2017
LexicalTag
ABX
ThesaurusID
NLM (2018)
-
HLA-Bw52
Term UI
T000915084
Date02/01/2017
LexicalTag
ABX
ThesaurusID
NLM (2018)
-
Cambridge Pathology 1 Antigen
Term UI
T000915073
Date02/01/2017
LexicalTag
NON
ThesaurusID
NLM (2016)
-
Lymphocyte Antigen CDw52
Term UI
T000915085
Date02/01/2017
LexicalTag
ABX
ThesaurusID
NLM (2018)